Maruyama Y, Feola J M, Magura C, Onomura C I, Beach J L
Int J Radiat Oncol Biol Phys. 1985 Nov;11(11):1991-7. doi: 10.1016/0360-3016(85)90282-2.
Dose response curves were determined for the LSA lymphoma for acute 60Co, low dose rate Cs-137 and Cf-252 radiations using in vivo survival time bioassay. Mean survival times increased with dose with a prominent oxygen effect noted for acute 60Co and Cs-137. OER was lowest for Cf-252 where it was approximately 1.4. The RBEn for oxic LSA cells to Cf-252 neutrons was 3.1 for acute 60Co and 4.2 for Cs-137. It was larger for hypoxic tumor and RBE was 5.3 for 60Co and 5.8 for Cs-137. Survival curves based on survival data used a multitarget dose-response model for photon radiation and exponential dose-response for Cf-252 radiation. When LSA was irradiated in advanced tumor stages in vivo, Cf-252 was much more effective than acute 60Co or LDR Cs-137 for increasing survival time. Tumor response in vivo matched the in vitro irradiated tumor data. No schedule dependence was observed for mixing of 60Co and Cf-252 radiations.
使用体内存活时间生物测定法,确定了LSA淋巴瘤对急性60Co、低剂量率Cs - 137和Cf - 252辐射的剂量反应曲线。平均存活时间随剂量增加,急性60Co和Cs - 137有显著的氧效应。Cf - 252的氧增强比最低,约为1.4。有氧LSA细胞对Cf - 252中子的相对生物效应因子,急性60Co照射时为3.1,Cs - 137照射时为4.2。缺氧肿瘤的该值更大,60Co照射时相对生物效应为5.3,Cs - 137照射时为5.8。基于存活数据的存活曲线,光子辐射采用多靶剂量反应模型,Cf - 252辐射采用指数剂量反应模型。当体内晚期肿瘤阶段的LSA受到照射时,Cf - 252在延长存活时间方面比急性60Co或低剂量率Cs - 137有效得多。体内肿瘤反应与体外照射肿瘤数据相符。未观察到60Co和Cf - 252辐射混合的疗程依赖性。